Type 2 Inflammation In Eosinophilic Chronic Obstructive Pulmonary Disease

Andrew Higham,Augusta Beech,Sophie Wolosianka,Natalie Jackson,Gabriella Long,Umme Kolsum,Thomas Southworth,Tuyet‐Hang Pham,Sriram Sridhar,Christopher McCrae,Paul Newbold,Dave Singh

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2020）

引用 26|浏览18

暂无评分

摘要

Type 2 (T2) inflammation in asthma encompasses the presence of eosinophilic inflammation and / or selected cytokines including interleukin (IL)-13. Some chronic obstructive pulmonary disease (COPD) patients have increased airway eosinophil numbers, which is associated with greater effects of inhaled corticosteroids (ICS). Studies of T2 inflammation in COPD have used hypothesis free, open platform approaches.

查看译文

关键词

inflammation,disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要